SEC Form 4 · accession 0001209191-17-037298
Pediatrix Medical Group, Inc. · MD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A. Clark
Officer — Pres. Mednax Natl Med Group
Period of report
Jun 1, 2017
Accepted (ET)
Jun 2, 2017 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000893949
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2017 | A | 15,277 | $0.00 | A | 35,302 | D | |
| Common StockF3 | Jun 1, 2017 | S | 10,202 | $54.9932 | D | 25,100 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.
- F2Sales made pursuant to Reporting Person's 10b5-1 trading plan.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in fifty-three (53) separate transactions with prices ranging from $54.16 to $55.39 for an average weighted sales price of $54.9932. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.